MGNX financials
MacroGenics (MGNX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- MGNX revenue was $149.50M in fiscal 2025, net income -$74.62M.
MGNX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $149.50M | $149.50M | -$72.84M | -$74.62M | -1.18 |
| 2024 | $149.96M | $149.12M | -$110.58M | -$66.97M | -1.07 |
| 2023 | $58.75M | $58.13M | -$168.24M | -$9.06M | -0.15 |
| 2022 | $151.94M | $148.59M | -$121.42M | -$119.76M | -1.95 |
| 2021 | $77.45M | $74.80M | -$202.79M | -$202.12M | -3.37 |
| 2020 | $104.88M | $104.88M | -$131.06M | -$129.74M | -2.47 |